We are monitoring the impact of COVID-19 on MEA Peptide Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2021
ID: 12046
Share on
Share on

Middle East and Africa Peptide Therapeutics Market Research Report – Segmented By Type, Application, Type of Manufacturers, Route of Administration, Synthesis Technology & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Analysis on Size, Share, Trends, COVID-19 Impact and Growth Forecast (2021 to 2026)

Pulished: August, 2021
ID: 12046
Pages: 100

MEA Peptide Therapeutics Market Size (2021 to 2026)

The size of the Middle East and African peptide therapeutics market is predicted to hike at a healthy CAGR from 2021 to 2026.

Factors include the increasing prevalence of cancer, increasing health expenditure, increasing incidence of metabolic disorders, increasing geriatric population, and accelerating the number of therapeutic drugs based on approved peptides.

The growing incidences of cancer and metabolic disorders, such as osteoporosis, obesity, and diabetes, are some of the main factors driving the growth of the peptide therapeutics market during the forecast period. In addition, the need for inexpensive and effective drugs is great due to the growth of the affected pediatric population and the incidence of target diseases in low-cost countries. The market will show a good growth rate for the peptide therapeutics market due to the various initiatives taken by many companies for the development of new drug candidates. CMOs offering a complete solution to biotech, pharmaceutical companies are increasing due to the shift in focus of pharmaceutical companies to seek better opportunities in the peptide therapy market.

The market is expected to experience some trends, such as expansion in the volume of generic peptides, rapid adoption of outsourced peptide APIs, and increased investment in research and development of new drugs. In addition, according to data from Omnia Health 2019, there is an increasing incidence of epidemic skin cancer data globally and in the region, which requires efforts to promote awareness and implement standardized screening programs. Patients living in areas with high average annual heatstroke, such as the United Arab Emirates, should take extra precautions to fight skin cancer. In the UAE, Skin cancer is one of the most commonly found malignancies, with a prevalence rate of 14.9%. Hence, the above-mentioned factor is likely to drive the growth of the market.

However, the operational limitations of peptides will restrain the growth of the market. Additionally, market growth would be compromised by the availability of generic or biosimilar peptide therapeutic drugs, the high cost of drug development, stringent regulatory requirements, and the complexity of peptide production.

Impact of COVID-19 on the MEA peptide therapeutics market:

MEA region has seen a dramatic increase in demand for the management of COVID-19, as the effectiveness of this drug is more useful than other drugs. Such high demand for these drugs has presented the greatest opportunity for major manufacturers of drugs to treat COVID-19. Furthermore, due to the increased demand for vaccines and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to experience significant growth in the future.

This research report on the Middle East and Africa peptide therapeutics market has been segmented and sub-segmented into the following categories:

By Type:

  • Generic
  • Innovative

By Application:

  • Metabolic
  • Cardiovascular Disorder
  • Respiratory
  • GIT
  • Anti-infection
  • Pain
  • Dermatology
  • CNS
  • Renal
  • Others

By Type of Manufacturers:

  • In-house
  • Outsourced

By Route of Administration:

  • Parenteral Route
  • Oral Route
  • Pulmonary
  • Mucosal
  • Others

By Synthesis Technology:

  • Solid Phase Peptide Synthesis (SPPS)
  • Liquid Phase Peptide Synthesis (LPPS)
  • Hybrid Technology

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, the Middle East region dominates the MEA peptide therapeutics market due to the increasing levels of awareness of peptide therapies, the growing demand for diagnostics of cancer and other diseases, and the growing biotechnology industry are factors that are mainly driving the growth of the market. Increased government R&D spending is also expected to help the peptide therapy market stay under control in the near future. In addition, a well-developed biopharmaceutical and pharmaceutical industry in this region will be an important factor for the market growth. The UAE is expected to show remarkable growth in the market due to huge unexplored opportunities, declining commodity prices, a growing base of companies offering outsourcing services, a booming biotechnology industry, and funding growth in the research and development sector. The cheap raw material prices and the expiration of patents on popular drugs that help the aging market provide tremendous growth opportunities for the MEA peptide therapy market.

The fastest-growing regional market is Saudi Arabia due to increased research and development activities for the development of innovative peptide therapies and improvements in healthcare infrastructure, as well as the increase in the prescription for peptide therapeutics due increase in a large number of patients with chronic diseases like diabetes and cancer that will help market growth in future.

KEY MARKET PLAYERS:

Eli Lilly and Company, Amgen, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Ever Neuro Pharma GmbH, Takeda Pharmaceutical Company Limited, AstraZeneca PLC, GlaxoSmithKline plc, Novo Nordisk A/S., Novartis AG, Zealand Pharma AG, AmbioPharm Inc., Bachem Holding AG, PolyPeptide Group, Sanofi SA, Amylin Pharmaceuticals, CirclePharma, Inc., PeptiDream Inc., Apitope Technology, Arch NioPartners, and Galena Biopharmaceuticals are some of the prominent companies operating in the MEA peptide therapeutics market.

  1. Introduction                                                          
    1. Market Definition                                               
    2. Scope of the report                                            
    3. Study Assumptions                                            
    4. Base Currency, Base Year and Forecast Periods                                                     
  2. Research Methodology                                                                    
    1. Analysis Design                                                   
    2. Research Phases                                                 
      1. Secondary Research                                       
      2. Primary Research                              
      3. Data Modelling                                 
      4. Expert Validation                              
    3. Study Timeline                                                    
  3. Report Overview                                                                 
    1. Executive Summary                                           
    2. Key Inferences                                                  
  4. Market Dynamics                                                                
    1. Impact Analysis                                                   
      1. Drivers                                  
      2. Restraints                              
      3. Opportunities                                    
    2. Regulatory Environment                                                  
    3. Technology Timeline & Recent Trends                                                      
  5. Competitor Benchmarking Analysis                                                             
    1. Key Player Benchmarking                                                
      1. Market share analysis                                    
      2. Products/Service                              
      3. Regional Presence                            
    2. Mergers & Acquisition Landscape                                                
    3. Joint Ventures & Collaborations                                                  
  6. Market Segmentation                                                                       
    1. Peptide Therapeutics Market, By Type
      1. Generic
      2. Innovative
      3. Market Size Estimations & Forecasts (2021-2026)                               
      4. Y-o-Y Growth Rate Analysis                                         
      5. Market Attractiveness Index                                       
    2. Peptide Therapeutics Market, By Application                                  
      1. Metabolic
      2. Cardiovascular Disorder
      3. Respiratory
      4. GIT
      5. Anti-infection
      6. Pain
      7. Dermatology
      8. CNS
      9. Renal
      10. Others
      11. Market Size Estimations & Forecasts (2021-2026)                               
      12. Y-o-Y Growth Rate Analysis                                         
      13. Market Attractiveness Index       
    3. Peptide Therapeutics Market, By Type of Manufacturers 
      1. In-house
      2. Outsourced
      3. Market Size Estimations & Forecasts (2021-2026)                               
      4. Y-o-Y Growth Rate Analysis                                         
      5. Market Attractiveness Index       
    4. Peptide Therapeutics Market, By Route of Administration
      1. Parenteral Route
      2. Oral Route
      3. Pulmonary
      4. Mucosal
      5. Others
      6. Market Size Estimations & Forecasts (2021-2026)                               
      7. Y-o-Y Growth Rate Analysis                                         
      8. Market Attractiveness Index       
    5. Peptide Therapeutics Market, By Synthesis Technology
      1. Solid Phase Peptide Synthesis (SPPS)
      2. Liquid Phase Peptide Synthesis (LPPS)
      3. Hybrid Technology
      4. Market Size Estimations & Forecasts (2021-2026)                               
      5. Y-o-Y Growth Rate Analysis                                         
      6. Market Attractiveness Index       
  7. Geographical Landscape                                                                  
    1. Middle East and Africa                                                     
      1. By Country                                         
        1. Middle East                      
        2. Africa                  
  8. Key Player Analysis                                                             
    1. Eli Lilly and Company
      1. Business Description                                      
      2. Products/Service                              
      3. Financials                             
      4. SWOT Analysis                                  
      5. Recent Developments                                    
      6. Analyst Overview                              
    2. Amgen, Inc.
    3. Pfizer, Inc.
    4. Bristol-Myers Squibb Company
    5. Ever Neuro Pharma GmbH
    6. Takeda Pharmaceutical Company Limited
    7. AstraZeneca PLC
    8. GlaxoSmithKline plc
    9. Novo Nordisk A/S.
    10. Novartis AG
    11. Zealand Pharma AG
    12. AmbioPharm Inc.
    13. Bachem Holding AG
    14. PolyPeptide Group
    15. Sanofi SA
    16. Amylin Pharmaceuticals
    17. CirclePharma, Inc.
    18. PeptiDream Inc.
    19. Apitope Technology
    20. Arch NioPartners
    21. Galena Biopharmaceuticals
  9. Market Outlook & Investment Opportunities                                                          
  10. Appendix                                               
    1. List of Tables
    2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of type, application, type of manufacturers, route of administration and synthesis technology along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Middle East and Africa Peptide Therapeutics Market, By Type, From 2021 to 2026 (USD Billion)
  2. Middle East and Africa Generic Market, By Region, From 2021 to 2026 (USD Billion)
  3. Middle East and Africa Innovative Market, By Region, From 2021 to 2026 (USD Billion)
  4. Middle East and Africa Peptide Therapeutics Market, By Application, From 2021 to 2026 (USD Billion)
  5. Middle East and Africa Metabolic Market, By Region, From 2021 to 2026 (USD Billion)
  6. Middle East and Africa Cardiovascular Disorder Market, By Region, From 2021 to 2026 (USD Billion)
  7. Middle East and Africa Respiratory Market, By Region, From 2021 to 2026 (USD Billion)
  8. Middle East and Africa GIT Market, By Region, From 2021 to 2026 (USD Billion)
  9. Middle East and Africa Anti-infection Market, By Region, From 2021 to 2026 (USD Billion)
  10. Middle East and Africa Pain Market, By Region, From 2021 to 2026 (USD Billion)
  11. Middle East and Africa Dermatology Market, By Region, From 2021 to 2026 (USD Billion)
  12. Middle East and Africa CNS Market, By Region, From 2021 to 2026 (USD Billion)
  13. Middle East and Africa Renal Market, By Region, From 2021 to 2026 (USD Billion)
  14. Middle East and Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  15. Middle East and Africa Peptide Therapeutics Market, By Type of Manufacturers, From 2021 to 2026 (USD Billion)
  16. Middle East and Africa In-house Market, By Region, From 2021 to 2026 (USD Billion)
  17. Middle East and Africa Outsourced Market, By Region, From 2021 to 2026 (USD Billion)
  18. Middle East and Africa Peptide Therapeutics Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  19. Middle East and Africa Parenteral Route Market, By Region, From 2021 to 2026 (USD Billion)
  20. Middle East and Africa Oral Route Market, By Region, From 2021 to 2026 (USD Billion)
  21. Middle East and Africa Pulmonary Market, By Region, From 2021 to 2026 (USD Billion)
  22. Middle East and Africa Mucosal Market, By Region, From 2021 to 2026 (USD Billion)
  23. Middle East and Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  24. Middle East and Africa Peptide Therapeutics Market, By Synthesis Technology, From 2021 to 2026 (USD Billion)
  25. Middle East and Africa Solid Phase Peptide Synthesis (SPPS) Market, By Region, From 2021 to 2026 (USD Billion)
  26. Middle East and Africa Liquid Phase Peptide Synthesis (LPPS) Market, By Region, From 2021 to 2026 (USD Billion)
  27. Middle East and Africa Hybrid Technology Market, By Region, From 2021 to 2026 (USD Billion)
  28. Middle East Peptide Therapeutics Market, By Type, From 2021 to 2026 (USD Billion)
  29. Middle East Peptide Therapeutics Market, By Application, From 2021 to 2026 (USD Billion)
  30. Middle East Peptide Therapeutics Market, By Type of Manufacturers, From 2021 to 2026 (USD Billion)
  31. Middle East Peptide Therapeutics Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  32. Middle East Peptide Therapeutics Market, By Synthesis Technology, From 2021 to 2026 (USD Billion)
  33. Africa Peptide Therapeutics Market, By Type, From 2021 to 2026 (USD Billion)
  34. Africa Peptide Therapeutics Market, By Application, From 2021 to 2026 (USD Billion)
  35. Africa Peptide Therapeutics Market, By Type of Manufacturers, From 2021 to 2026 (USD Billion)
  36. Africa Peptide Therapeutics Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  37. Africa Peptide Therapeutics Market, By Synthesis Technology, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample